Skip to main content

Table 4 Adjusted associations between cardiovascular risk factors and arterial calcification in the five arterial regions

From: Regional distribution and severity of arterial calcification in patients with chronic kidney disease stages 1–5: a cross-sectional study of the Copenhagen chronic kidney disease cohort

Variable

Total carotid arteries

(n = 526)

Total coronary arteries

(n = 535)

Total thoracic aorta

(n = 494)

Abdominal aorta

(n = 525)

Total iliac arteries

(n = 502)

IRR (95%CI)

P-value

IRR (95%CI)

P-value

IRR (95%CI)

P-value

IRR (95%CI)

P-value

IRR (95%CI)

P-value

Age (y)

1.09 (1.06–1.11)

0.000

1.10 (1.07–1.13)

0.000

1.20 (1.18–1.23)

0.000

1.14 (1.12–1.16)

0.000

1.13 (1.10–1.15)

0.000

Male sex

0.98 (0.55–1.80)

0.994

2.33 (1.35–4.00)

0.002

0.87 (0.60–1.27)

0.482

1.21 (0.82–1.78)

0.331

2.31 (1.55–3.45)

0.000

Hypertension

3.17 (1.53–6.55)

0.002

1.92 (0.97–3.80)

0.061

3.11 (1.73–5.56)

0.000

2.67 (1.54–4.62)

0.000

2.09 (1.19–3.69)

0.011

Diabetes

1.99 (1.01–3.91)

0.05

1.68 (0.88–3.22)

0.119

0.89 (0.52–1.49)

0.647

1.11 (0.66–1.88)

0.395

1.29 (0.75–2.21)

0.353

Cholestesterol- lowering medication

1.66 (0.98–2.82)

0.058

1.88 (1.11–3.20)

0.020

2.54 (1.67–3.86)

0.000

1.65 (1.09–2.51)

0.018

1.66 (1.09–2.55)

0.019

Per 10 units increase in pack-years of smoking

1.23 (1.09–1.39)

0.001

1.08 (0.97–1.21)

0.358

1.29 (1.16–1.43)

0.000

1.21 (1.10–1.34)

0.000

1.30 (1.17–1.45)

0.000

Anticoagulants (Warfarin)

1.36 (0.53–3.48)

0.517

3.36 (1.34–8.44)

0.010

1.70 (0.82–3.55)

0.156

1.65 (0.80–3.42)

0.117

1.76 (0.82–3.76)

0.146

Per 10 units decrease in creatinine clearance (ml/min)

1.03 (0.96–1.10)

0.367

1.08 (1.02–1.14)

0.012

1.04 (1.01–1.08)

0.037

1.03 (0.98–1.08)

0.186

1.01 (0.95–1.06)

0.797

  1. IRR incidence rate ratio, CI Confidence interval